Key result
Stimulation of endogenous PKA phosphorylated membrane-bound CaM kinase II and activated the Ca2+ pump approximately 2-fold, an effect blocked by the CaM kinase II inhibitor KN-93.
CaM kinase II acts as an essential intermediate in the complex regulatory network of the electrocyte Ca2+ pump involving calmodulin and PKA.
This is the authors' abstract. We don't add key points for this paper.
The aim of this study was to investigate (a) whether Ca2+/calmodulin-dependent protein kinase II (CaM kinase II) participates in the regulation of plasma membrane Ca2+-ATPase and (b) its possible cross-talk with other kinase-mediated modulatory pathways of the pump. Using isolated innervated membranes of the electrocytes from Electrophorus electricus L., we found that stimulation of endogenous protein kinase A (PKA) strongly phosphorylated membrane-bound CaM kinase II with simultaneous substantial activation of the Ca2+ pump (approximately 2-fold). The addition of cAMP (5-50 pM), forskolin (10 nM), or cholera toxin (10 or 100 nM) stimulated both CaM kinase II phosphorylation and Ca2+-ATPase activity, whereas these activation processes were cancelled by an inhibitor of the PKA alpha-catalytic subunit. When CaM kinase II was blocked by its specific inhibitor KN-93, the Ca2+-ATPase activity decreased to the levels measured in the absence of calmodulin; the unusually high Ca2+ affinity dropped 2-fold; and the PKA-mediated stimulation of Ca2+-ATPase was no longer seen. Hydroxylamine-resistant phosphorylation of the Ca2+-ATPase strongly increased when the PKA pathway was activated, and this phosphorylation was suppressed by inhibition of CaM kinase II. We conclude that CaM kinase II is an intermediate in a complex regulatory network of the electrocyte Ca2+ pump, which also involves calmodulin and PKA.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications; leaves open whether CaM kinase II mediates PKA effects on cardiac Ca2+ handling.
No takes yet. Share an insight, caveat, or question.
Valverde et al. (2005) studied this question. PKA pathway activators (cAMP, forskolin, cholera toxin) and CaM kinase II inhibitor (KN-93) was evaluated on Ca2+-ATPase activity and CaM kinase II phosphorylation. Stimulation of endogenous PKA phosphorylated membrane-bound CaM kinase II and activated the Ca2+ pump approximately 2-fold, an effect blocked by the CaM kinase II inhibitor KN-93.
Synapse has enriched 10 related papers. Consider them for comparative context: